首页|硫酸羟氯喹与他克莫司软膏治疗对玫瑰痤疮患者临床疗效的影响

硫酸羟氯喹与他克莫司软膏治疗对玫瑰痤疮患者临床疗效的影响

扫码查看
目的 探讨予以玫瑰痤疮患者硫酸羟氯喹+他克莫司软膏的疗效.方法 回顾性分析 2021 年 1 月-2023 年 3 月在巴音郭楞蒙古自治州人民医院皮肤科就诊的92例玫瑰痤疮患者的病历资料,根据就诊时间先后进行分组,将2021年1月-2022年 1 月应用他克莫司软膏的46 例患者分为对照组,将2022 年 2 月-2023 年 3 月应用硫酸羟氯喹联合他克莫司软膏治疗的46例患者分为观察组.两均持续治疗 8 周.对比两组症状积分、临床疗效、皮肤屏障功能、生活质量[生活质量综合评定问卷(GQOLI-74)]及不良反应.结果 观察组治疗后瘙痒、红斑、毛细血管、丘疹及脓疱症状积分均低于对照组,(P<0.05);观察组临床总有效率(95.65%)高于对照组(82.61%),(P<0.05);观察组治疗后角质层含水量水平高于对照组,皮脂情况水平低于对照组,(P<0.05);观察组治疗后GQOLI-74 量表中各维度评分均高于对照组,(P<0.05);两组不良反应发生率相比,(P>0.05).结论 予以玫瑰痤疮以硫酸羟氯喹+他克莫司软膏治疗,可促进临床症状恢复,改善皮肤屏障功能,疗效显著,利于提升患者生活质量,且具有较好的治疗安全性.
The effect of hydroxychloroquine sulfate and tacrolimus ointment on the time for symptom improvement in patients with rosacea
Objective Exploring the therapeutic effect of hydroxychloroquine sulfate combined with tacrolimus ointment on patients with rosacea.Method A retrospective analysis was conducted on the medical records of 92 patients with rosacea who visited the dermatology department of Bayingolin Mongolian Autonomous Prefecture People's Hospital from January 2021 to March 2023.They were grouped according to the time of visit.46 patients who received tacrolimus ointment from January 2021 to January 2022 were divided into a control group,and 46 patients who received hydroxychloroquine sulfate combined with tacrolimus ointment from February 2022 to March 2023 were divided into an observation group.Both continued treatment for 8 weeks.Compare the symptom scores,clinical efficacy,skin barrier function,quality of life(GQOLI-74),and adverse reactions between two groups.Result The symptom scores of itching,erythema,capillaries,papules,and pustules in the observation group were lower than those in the control group after treatment(P<0.05);The total clinical effective rate of the observation group(95.65%)was higher than that of the control group(82.61%),(P<0.05);After treatment,the water content in the stratum corneum of the observation group was higher than that of the control group,and the sebum level was lower than that of the control group(P<0.05);After treatment,the scores of all dimensions in the GQOLI-74 scale in the observation group were higher than those in the control group(P<0.05);The incidence of adverse reactions in the two groups was compared(P>0.05).Conclusion Treating rosacea with hydroxychloroquine sulfate and tacrolimus ointment can promote clinical symptom recovery,improve skin barrier function,and have significant therapeutic effects,which is beneficial for improving the quality of life of patients and has good treatment safety.

Rose acneHydroxychloroquinone sulfateTacrolimus ointmentSymptom scoreAdverse reactions

张玉、袁永革

展开 >

巴音郭楞蒙古自治州人民医院皮肤科,新疆 库尔勒,841000

玫瑰痤疮 硫酸羟氯喹 他克莫司软膏 症状积分 不良反应

2024

中国医疗美容
中国整形美容协会

中国医疗美容

影响因子:0.454
ISSN:2095-0721
年,卷(期):2024.14(3)
  • 21